Update Mid-Year 1 for Clinical Trial Regarding Use of Regenerative Medicine to Treat Tendon Injury in Dogs

Update from the middle of year 1 in the clinical trial to establish evidence-base use of regenerative medicine in the treatment of tendon injury in dogs.

We are actively recruiting canine patients (all breeds and mixed breeds) with unilateral lameness originating at the shoulder, with no signs of osteoarthritis on radiographs.

If you or someone you know has a dog with primary unilateral lameness originating at the shoulder please consider participating and contact CHF or the contacts below for more information.

In this study, platelet rich plasma (PRP) will be combined with one of two types of cell therapy: concentrated adipose stem cells (ASC) and a mixture of adipose-derived cells called the stromal vascular fraction (SVF). This clinical trial is blinded and placebo-controlled.

Jayme Schatz, Surgical Coordinator Email: jschatz@vosm.com | Phone: (240) 295-4400 Ext. 210

Katie Cox, Research Technician Email: kcox@vosm.com | Phone: (240) 295-4400 Ext. 215

Please note: This study takes place at Veterinary Orthopedic & Sports Medicine Group, Annapolis Junction, MD. Cell processing will be done off-site at the Equine Medical Center in Leesburg, VA.